Inverted variant of Takotsubo Syndrome caused by inhaled adrenergic beta-2 agonists

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Takotsubo syndrome (TS) is an acute and reversible clinical syndrome characterized by transient hypokinesis of the left ventricular (LV) apex. Variant forms of LV dysfunction have been reported, including inverted Takotsubo syndrome (ITS), which represents only 5% of cases and has previously been linked to excessive use of inhaled adrenergic beta-2 agonists. The authors describe the case of a 60-year-old female patient who was diagnosed with ITS after the excessive use of inhaled adrenergic beta-2 agonists. This case highlights an uncommon variant of this syndrome that may not be obvious and must be suspected in this particular context. LEARNING POINTS • Takotsubo syndrome (TS) was initially described with a classic pattern of LV apical akinesis and accounts for around 75–80% of cases. Variants including inverted Takotsubo (also known as basal variant) can affect other areas of the myocardium. • Several physiopathological mechanisms have been implicated. Catecholamine-induced cardiotoxicity is one of the most supported theories, while other triggers, including excessive use of inhaled beta-2 agonists, have also been described. • Treatment of TS is mainly symptomatic and conservative and frequently leads to rapid resolution and LV function recovery.

Cite

CITATION STYLE

APA

de Sousa, M., Casado, A., Marques, A. B., Machado, F. P., & Esperança, I. (2018). Inverted variant of Takotsubo Syndrome caused by inhaled adrenergic beta-2 agonists. European Journal of Case Reports in Internal Medicine, 5(4). https://doi.org/10.12890/2018_000831

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free